Pettorruso, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 1.396
AS - Asia 1.076
EU - Europa 1.058
SA - Sud America 194
AF - Africa 30
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.767
Nazione #
US - Stati Uniti d'America 1.359
SG - Singapore 515
DE - Germania 366
CN - Cina 245
BR - Brasile 160
IT - Italia 151
SE - Svezia 131
FR - Francia 121
VN - Vietnam 96
GB - Regno Unito 83
UA - Ucraina 53
IN - India 47
IE - Irlanda 40
JP - Giappone 36
FI - Finlandia 33
ID - Indonesia 25
HK - Hong Kong 23
CA - Canada 16
RU - Federazione Russa 16
AR - Argentina 13
MX - Messico 13
NL - Olanda 13
AU - Australia 11
BD - Bangladesh 11
AT - Austria 10
TR - Turchia 10
ES - Italia 9
KR - Corea 9
ZA - Sudafrica 9
IR - Iran 8
PK - Pakistan 8
PL - Polonia 8
IQ - Iraq 7
KE - Kenya 6
MA - Marocco 6
VE - Venezuela 6
BE - Belgio 5
EG - Egitto 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
OM - Oman 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EC - Ecuador 3
KZ - Kazakistan 3
LT - Lituania 3
PT - Portogallo 3
UY - Uruguay 3
BZ - Belize 2
CI - Costa d'Avorio 2
CO - Colombia 2
GR - Grecia 2
HU - Ungheria 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GL - Groenlandia 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MC - Monaco 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.767
Città #
Singapore 269
Chandler 213
San Jose 148
Ashburn 121
New York 48
Beijing 43
St Louis 40
Dublin 38
San Mateo 37
Rome 36
Lauterbourg 35
Los Angeles 34
Jacksonville 32
Hanoi 31
Hefei 31
Milan 31
Tokyo 31
The Dalles 30
Wilmington 30
Munich 28
Ho Chi Minh City 26
Jakarta 24
Dallas 22
Hong Kong 20
Marseille 20
Boston 19
Dearborn 18
Nanjing 18
Frankfurt am Main 17
Nürnberg 15
São Paulo 14
Buffalo 13
Helsinki 13
Falls Church 12
Houston 12
Lawrence 12
Moscow 12
Woodbridge 12
Ann Arbor 11
Council Bluffs 11
Seattle 11
Falkenstein 10
Fairfield 9
Lancaster 9
London 9
Mexico City 9
Poitiers 9
Princeton 9
Redwood City 9
Seoul 9
Boardman 8
Cattolica 7
Chicago 7
Guangzhou 7
Kent 7
Montreal 7
Santa Clara 7
Bremen 6
Chennai 6
Nanchang 6
Norwalk 6
Orem 6
Paris 6
Poplar 6
Vienna 6
Brisbane 5
Changsha 5
Columbus 5
Kish 5
Mountain View 5
Newark 5
Nuremberg 5
San Diego 5
Stockholm 5
Swansea 5
Toronto 5
Amsterdam 4
Atlanta 4
Augusta 4
Baghdad 4
Bexley 4
Brooklyn 4
Cairo 4
Cape Town 4
Cardiff 4
Chelmsford 4
Da Nang 4
Haiphong 4
Jiaxing 4
Lappeenranta 4
Montes Claros 4
Pune 4
Rio de Janeiro 4
Roubaix 4
Tianjin 4
Tredegar 4
Turku 4
Warsaw 4
Wroclaw 4
Baku 3
Totale 1.968
Nome #
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 317
Dopamine transporter availability in gambling disorder: preliminary 123I-FP-CIT SPECT results 203
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 172
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 162
Allostasis as a conceptual framework linking bipolar disorder and addiction 147
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 143
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 143
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 134
Amantadine in the treatment of pathological gambling: a case report 130
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 128
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 127
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 124
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 123
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 123
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 121
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 116
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 112
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 111
Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services 104
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 103
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 93
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 91
Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study. 89
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder 86
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 84
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 69
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 63
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 62
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 60
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 58
Resilience and childhood trauma in mood disorders: Psychopathological implications and treatment response 42
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study 39
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 34
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group 33
Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 28
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown 26
Italian REMS, limits and critical issues: From a clinical case to the comparison with the European forensic systems 26
Totale 3.826
Categoria #
all - tutte 14.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.091


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 16 26 5
2021/2022227 18 10 3 3 15 11 12 42 11 17 35 50
2022/2023538 61 72 45 99 18 69 23 56 67 6 11 11
2023/2024210 17 68 3 4 8 52 8 0 1 7 20 22
2024/2025586 4 23 32 17 47 10 43 26 93 46 133 112
2025/20261.496 213 56 85 145 274 115 308 83 102 115 0 0
Totale 3.826